RKT Stock Slips As JPMorgan Trims Target And FTC Trial Looms

Rocket Companies Inc. stocks have been trading down by -3.78 percent amid weak mortgage demand and housing market headwinds.

Live Update At 16:01:57 EDT: On Monday, July 20, 2026 Rocket Companies Inc. stock [NYSE: RKT] is trending down by -3.78%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

RKT has been grinding lower over the past few weeks, and the tape shows that pressure clearly. From late June to the latest close, Rocket Companies slipped from the mid‑$15s to around $14, with recent daily closes clustering between $13.99 and $14.60. That’s a controlled pullback, not a crash, but it tells traders momentum has cooled.

Intraday, RKT’s 5‑minute chart shows a tight range day, mostly between $13.80 and $14.20, with no major trend after the open fade from $14.67. That intraday chop signals indecision. Dip buyers are stepping in near $13.80, but there’s no aggressive push back toward $15.

More Breaking News

• CRDO Stock Draws Aggressive Targets As AI Connectivity Bets Grow
• ELF Stock Climbs As Wall Street Hikes Price Targets
• TRUG Slides After Volatile Spike Draws Short-Term Focus
• TRVI Surges As Trevi Therapeutics Draws Aggressive Buyers

Fundamentally, Rocket Companies is posting real earnings, but the valuation is rich. A price/earnings ratio above 112 and a price/sales near 5.4 say traders are paying up for growth and stability in a choppy mortgage market. Revenue over the last year was roughly $4.42B, and Q1 2026 net income was $297M, with a pretax margin around 12%. Leverage is meaningful: long‑term debt of about $26.3B against equity of $23.2B. The good news is cash generation is strong, with roughly $1.86B in operating cash flow and $1.81B in free cash flow in the latest quarter, giving RKT some cushion as sentiment swings.

Why Traders Are Watching RKT Now

RKT is on watch because the story has shifted from clean growth to “show me” mode. Two fresh headlines are driving that tone. First, JPMorgan just trimmed its Rocket Companies price target from $16 to $15.50 while keeping a Neutral rating in a broader consumer‑finance reset ahead of Q2 earnings. That’s not a disaster call, but it’s a clear message: upside looks more limited in the near term.

For active traders, a Neutral from a big bank on RKT means the street does not see a strong edge long or short at current levels. When a price target cut comes without a downgrade, it usually reflects lower return expectations, not a thesis blow‑up. Still, to short‑term traders, that new $15.50 target sits only modestly above the recent $14 trading zone, shrinking the perceived reward.

The second driver is bigger for risk sentiment. Rocket’s Redfin unit and Zillow are now heading to an August trial after a court denied the FTC’s request for an early judgment in its challenge to their apartment‑listing partnership. RKT dropped 3.3% on that news alone. The market hates uncertainty, and a full FTC trial means months of headlines and scenario‑spinning around that Redfin–Zillow relationship.

For Rocket Companies, the issue is not just legal fees. Traders worry about potential changes to the structure or economics of that partnership if the FTC prevails. That fear shows up in the chart: every regulatory headline becomes a sell trigger. RKT traders are now forced to factor in a legal overhang on top of rate and housing‑cycle noise, which already drive volatility in mortgage‑linked names.

Conclusion

Put it together and RKT is sitting in a tricky zone. The chart shows a steady drift from $15–$16 down toward $14, while the intraday action in Rocket Companies has tightened into a choppy band with no clear direction. The fundamentals show solid revenue and strong free cash flow, but also a high valuation and meaningful leverage. Layer on a JPMorgan target cut to $15.50 and a Neutral label, and you get a stock that the sell side respects, but isn’t excited about near term.

Then add the August FTC trial over the Redfin–Zillow apartment‑listing partnership, and the risk profile changes again. Traders in RKT now have to navigate both earnings‑season expectations and a regulatory storyline that already knocked the shares down 3.3% on one headline. That kind of overhang often caps rallies until the market sees a firm outcome.

For active traders, this is textbook watch‑list material, not a blind swing. As Tim Sykes loves to remind his students, “The market doesn’t care about your opinion, it cares about the catalyst and the chart.” And as Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. With Rocket Companies, the catalysts are clear: Q2 earnings, the JPMorgan reset, and the FTC trial. The key now is to let RKT’s price action around those dates tell you whether the next big move is a squeeze back toward $16 or a breakdown through recent support. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.